These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10941297)

  • 1. [Adjuvant treatment of breast cancer: meta-analysis and therapeutic recommendations].
    Jerusalem G; Bours V; Fillet G
    Rev Med Liege; 2000 May; 55(5):356-9. PubMed ID: 10941297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Respective indications for hormone therapy, induction chemotherapy and adjuvant chemotherapy in breast cancer without clinically discernable distant metastases].
    Roy JA; Piccart MJ
    Rev Med Brux; 1995; 16(4):242-4. PubMed ID: 7481234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adjuvant chemotherapy in primary carcinoma of the breast].
    Harbeck N
    Zentralbl Gynakol; 2003 Sep; 125(9):322-6. PubMed ID: 14569511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recommendations for adjuvant chemo- and hormone therapy of breast carcinoma].
    Ridwelski K; Fahlke J
    Zentralbl Chir; 1998; 123 Suppl 5():142-6. PubMed ID: 10063600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adjuvant treatment of breast cancer in 2004. A review of the 8th consensus conference of St. Gallen and new study results].
    Kahlert S; von Koch F; Ditsch N; Untch M
    Gynakol Geburtshilfliche Rundsch; 2004 Apr; 44(2):102-12. PubMed ID: 15073439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the adjuvant treatment of postmenopausal women with endocrine-responsive breast cancer: past, present and future recommendations.
    Thuerlimann B; Koeberle D; Senn HJ
    Eur J Cancer; 2007 Jan; 43(1):46-52. PubMed ID: 17085045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant chemotherapy for primary breast cancer--review of 1998 St. Gallen's conference].
    Taguchi T
    Gan To Kagaku Ryoho; 1999 Aug; 26(9):1227-41. PubMed ID: 10478174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early-stage breast cancer - strategies for adjuvant systemic therapy].
    Görner M; Just M; Gerull S
    Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):230-8. PubMed ID: 18716990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing guidelines for adjuvant endocrine therapy in postmenopausal women with breast cancer: a coming of age.
    Verma S; Jackisch C
    Expert Rev Anticancer Ther; 2011 Feb; 11(2):277-86. PubMed ID: 21342045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Breast carcinoma--adjuvant chemo- and hormone therapy].
    Fey MF
    Ther Umsch; 1998 Jul; 55(7):413-4. PubMed ID: 9702106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?
    Pagani O; Senkus E; Wood W; Colleoni M; Cufer T; Kyriakides S; Costa A; Winer EP; Cardoso F;
    J Natl Cancer Inst; 2010 Apr; 102(7):456-63. PubMed ID: 20220104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary adjuvant treatment of breast cancer.
    Akerley WL
    Surg Oncol Clin N Am; 1995 Oct; 4(4):685-99. PubMed ID: 8535905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing practice in systemic breast cancer adjuvant treatment in a well-defined French population.
    Chaplain G; Coudert B; Milan C; Altwegg T; Esteve J
    Bull Cancer; 1999 Oct; 86(10):855-60. PubMed ID: 10572236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer.
    Hébert-Croteau N; Brisson J; Latreille J; Rivard M; Abdelaziz N; Martin G
    J Clin Oncol; 2004 Sep; 22(18):3685-93. PubMed ID: 15289491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].
    Tuxen MK; Nielsen DL; Lindberg H; Kamby C
    Ugeskr Laeger; 2007 Jan; 169(4):297-9. PubMed ID: 17274922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized adjuvant therapies: lessons from the past: the opening address by the St. Gallen 2013 award recipient.
    Goldhirsch A
    Breast; 2013 Aug; 22 Suppl 2():S3-7. PubMed ID: 24074788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elderly breast cancer patients: adjuvant chemotherapy and adjuvant endocrine therapy.
    Biganzoli L; Aapro M
    Gynakol Geburtshilfliche Rundsch; 2005 Jun; 45(3):137-42. PubMed ID: 15990438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.